Novavaxs Effort to Vaccinate the World, From Zero to Not Quite Warp Speed

Novavax’s Effort to Vaccinate the World, From Zero to Not Quite Warp Speed

Novavax is a vaccine company that, despite $2 billion in new federal and international funding, still hasn’t come through with a licensed covid vaccine. It hopes it can still help to fight the global covid scourge, but will it deliver? …

What’s Causing Michigan’s COVID Surge, and Who’s Getting Sick?

An anesthesiologist at the University of Michigan describes the new influx of patients and what this may mean for the pandemic’s trajectory

— Read more on ScientificAmerican.com

Scientific American Magazine…

To Extract More Doses per Vial, Vaccinators Put Squeeze on FDA to Relax Vaccine Handling Advice

Arthur Allen March 12, 2021 President Joe Biden has promised enough covid vaccine to immunize every willing adult by June 1. But right now, the gap between supply and demand is so dramatic that vaccinators are discovering ways to suck the final drops out of each vaccine vial — if federal regulators will let them. Pharmacists …

Read more

Massive Google-Funded COVID Database Will Track Variants and Immunity

Open repository will give free access to more than 160 million data points with details about individual infections

— Read more on ScientificAmerican.com

Scientific American Magazine…

How Will the Coronavirus Evolve?

How Will the Coronavirus Evolve?

With declining rates of new infections and the rollout of vaccines, some are beginning to speak of an end to COVID-19. But that rhetoric, in my opinion, is ill-considered and premature. Based on what we know now of SARS-CoV-2, it may no longer be a question of months before an end to the pandemic but a question of years, if not decades. We should plan for it.

COVID Vaccines Are Safe and Effective–What the Research Says

As more coronavirus vaccines are rolled out, researchers are learning about the extent and nature of side effects. | Charlotte’s Truth-Parade Reports Scientific American Magazine Article

Coronavirus News Roundup, February 6 – February 12

Pandemic highlights for the week from ScientificAmerican.com

Community Use of Cloth Masks to Control the Spread of SARS-CoV-2

Scientific Brief: Community Use of Cloth Masks to Control the Spread of SARS-CoV-2

Scientific Brief: Community Use of Cloth Masks to Control the Spread of SARS-CoV-2 | Masks are primarily intended to reduce the emission of virus-laden droplets (“source control”), which is especially relevant for asymptomatic or presymptomatic infected wearers who feel well and may be unaware of their infectiousness to others, and who are estimated to account for more than 50% of transmissions.1,2 Masks also help reduce inhalation of these droplets by the wearer (“filtration for personal protection”). The community benefit of masking for SARS-CoV-2 control is due to the combination of these effects; individual prevention benefit increases with increasing numbers of people using masks consistently and correctly.

Vaccine Hurdles - WHO

WHO Director Calls for Easing of Vaccine Hurdles for Developing Nations

WHO Director Calls for Easing of Vaccine Hurdles for Developing Nations | Lisa Schnirring | News Editor | CIDRAP News – | Jan 08, 2021 | “Vaccine nationalism hurts us all and is self-defeating.” Source: Center for Infectious Disease Research and Policy…